4D Pharma (DDDD)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 41.55p
   
  • Change Today:
      0.000p
  • 52 Week High: 129.00
  • 52 Week Low: 23.50
  • Currency: UK Pounds
  • Shares Issued: 109.49m
  • Volume: 0
  • Market Cap: 45.49m

Financial Analysis

Select chart: EPS | Dividend | Revenue

Key Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-15 n/a (10.06) (12.62)p n/a n/a n/a n/a 0.0%
31-Dec-16 n/a (11.71) (15.21)p n/a n/a n/a n/a 0.0%
31-Dec-17 n/a (23.99) (26.08)p n/a n/a n/a n/a 0.0%
31-Dec-18 n/a (28.44) (36.17)p n/a n/a n/a n/a 0.0%
31-Dec-19 0.21 (29.43) (36.75)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 n/a n/a n/a n/a n/a n/a n/a 0.0%
31-Dec-21 n/a n/a n/a n/a n/a n/a n/a 0.0%

Copyright © 2020 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest n/a n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

4D Pharma Market Data

Currency UK Pounds
Share Price 41.55p
Change Today 0.000p
% Change 0.00 %
52 Week High 129.00
52 Week Low 23.50
Volume 0
Shares Issued 109.49m
Market Cap 45.49m

4D Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
26.24% below the market average26.24% below the market average26.24% below the market average26.24% below the market average26.24% below the market average
20% below the sector average20% below the sector average20% below the sector average20% below the sector average20% below the sector average
Price Trend
89.23% below the market average89.23% below the market average89.23% below the market average89.23% below the market average89.23% below the market average
92.98% below the sector average92.98% below the sector average92.98% below the sector average92.98% below the sector average92.98% below the sector average
Income Not Available
Growth Not Available

4D Pharma Dividends

No dividends found

Trades for --2020

Time Volume / Share Price
0 @ 0.000p

4D Pharma Key Personnel

CEO Duncan Joseph Peyton

Top of Page